Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s10577-015-9505-5.

Title:
Centrosome amplification, chromosomal instability and cancer: mechanistic, clinical and therapeutic issues | Chromosome Research
Description:
Centrosomes, the main microtubule-organizing centers in most animal cells, are of crucial importance for the assembly of a bipolar mitotic spindle and subsequent faithful segregation of chromosomes into two daughter cells. Centrosome abnormalities can be found in virtually all cancer types and have been linked to chromosomal instability (CIN) and tumorigenesis. Although our knowledge on centrosome structure, replication, and amplification has greatly increased within recent years, still only very little is known on nature, causes, and consequences of centrosome aberrations in primary tumor tissues. In this review, we summarize our current insights into the mechanistic link between centrosome aberrations, aneuploidy, CIN and tumorigenesis. Mechanisms of induction and cellular consequences of aneuploidy, tetraploidization and CIN, as well as origin and effects of supernumerary centrosomes will be discussed. In addition, animal models for both CIN and centrosome amplification will be outlined. Finally, we describe approaches to exploit centrosome amplification, aneuploidy and CIN for novel and specific anticancer treatment strategies based on the modulation of chromosome missegregation rates.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Business & Finance
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don't see any clear sign of profit-making.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

pubmed, google, scholar, article, cas, central, cancer, cell, centrosome, cells, instability, biol, chromosome, aneuploidy, amplification, human, nat, chromosomal, mitotic, res, protein, kinase, genet, sci, spindle, krämer, nature, tumor, van, oncogene, duensing, cycle, mol, proc, natl, acad, centrosomes, leukemia, tumorigenesis, mitosis, wang, science, missegregation, checkpoint, rev, myeloid, amon, aberrations, multipolar, mammalian,

Topics {✒️}

cre-loxp-controlled periodic aurora month download article/chapter p53-dependent apoptosis pathway ubiquitin-conjugating enzyme e2 high-risk human papillomavirus cyclin-dependent kinase 2 p53-dependent postmitotic checkpoint s-phase-targeting anticancer drugs radiation-induced mitotic catastrophe 17-n-allylamino-17-demethoxygeldanamycin aicar main microtubule-organizing centers microtubule-stabilizing agents epothilones carrillo-de-santa-pau bueno-de-mesquita hb syndrome-related myeloid disorders nci-60 drug-screening panel somatic copy-number alteration quantitative multi-parametric evaluation aneuploidy-selective antiproliferation compounds cdc20 promotes tumorigenesis full article pdf mutated ha-ras-1 allele centrosome-declustering drugs mediate inhibits centrosomal clustering dna damage occurs article cosenza centrosome amplification induced kinesin-related protein potential anticancer agent stolzenberg-solomon rz diaz-martinez la human tetraploid cells p53-dependent mechanism über asymmetrische zelltheilung von lilienfeld-toal acentriolar mitosis activates additional chromosomal abnormality privacy choices/manage cookies dna damage response robust spindle checkpoint van der burg stil−/− mouse embryos fielding ab bakhoum sf hsf1 activation supports ubch10 ubiquitin conjugase peloponese jm jr abnormal centrosome amplification multiple molecular targets integrin-linked kinase

Questions {❓}

  • Nigg EA (2002) Centrosome aberrations: cause or consequence of cancer progression?
  • Weaver BAA, Cleveland DW (2006) Does aneuploidy cause cancer?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Centrosome amplification, chromosomal instability and cancer: mechanistic, clinical and therapeutic issues
         description:Centrosomes, the main microtubule-organizing centers in most animal cells, are of crucial importance for the assembly of a bipolar mitotic spindle and subsequent faithful segregation of chromosomes into two daughter cells. Centrosome abnormalities can be found in virtually all cancer types and have been linked to chromosomal instability (CIN) and tumorigenesis. Although our knowledge on centrosome structure, replication, and amplification has greatly increased within recent years, still only very little is known on nature, causes, and consequences of centrosome aberrations in primary tumor tissues. In this review, we summarize our current insights into the mechanistic link between centrosome aberrations, aneuploidy, CIN and tumorigenesis. Mechanisms of induction and cellular consequences of aneuploidy, tetraploidization and CIN, as well as origin and effects of supernumerary centrosomes will be discussed. In addition, animal models for both CIN and centrosome amplification will be outlined. Finally, we describe approaches to exploit centrosome amplification, aneuploidy and CIN for novel and specific anticancer treatment strategies based on the modulation of chromosome missegregation rates.
         datePublished:2015-12-08T00:00:00Z
         dateModified:2015-12-08T00:00:00Z
         pageStart:105
         pageEnd:126
         sameAs:https://doi.org/10.1007/s10577-015-9505-5
         keywords:
            Aneuploidy
            Centrosome
            Chromosomal instability
            Cell Biology
            Human Genetics
            Animal Genetics and Genomics
            Plant Genetics and Genomics
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10577-015-9505-5/MediaObjects/10577_2015_9505_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10577-015-9505-5/MediaObjects/10577_2015_9505_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10577-015-9505-5/MediaObjects/10577_2015_9505_Fig3_HTML.gif
         isPartOf:
            name:Chromosome Research
            issn:
               1573-6849
               0967-3849
            volumeNumber:24
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Netherlands
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Marco Raffaele Cosenza
               affiliation:
                     name:University of Heidelberg
                     address:
                        name:Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Alwin Krämer
               affiliation:
                     name:University of Heidelberg
                     address:
                        name:Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Centrosome amplification, chromosomal instability and cancer: mechanistic, clinical and therapeutic issues
      description:Centrosomes, the main microtubule-organizing centers in most animal cells, are of crucial importance for the assembly of a bipolar mitotic spindle and subsequent faithful segregation of chromosomes into two daughter cells. Centrosome abnormalities can be found in virtually all cancer types and have been linked to chromosomal instability (CIN) and tumorigenesis. Although our knowledge on centrosome structure, replication, and amplification has greatly increased within recent years, still only very little is known on nature, causes, and consequences of centrosome aberrations in primary tumor tissues. In this review, we summarize our current insights into the mechanistic link between centrosome aberrations, aneuploidy, CIN and tumorigenesis. Mechanisms of induction and cellular consequences of aneuploidy, tetraploidization and CIN, as well as origin and effects of supernumerary centrosomes will be discussed. In addition, animal models for both CIN and centrosome amplification will be outlined. Finally, we describe approaches to exploit centrosome amplification, aneuploidy and CIN for novel and specific anticancer treatment strategies based on the modulation of chromosome missegregation rates.
      datePublished:2015-12-08T00:00:00Z
      dateModified:2015-12-08T00:00:00Z
      pageStart:105
      pageEnd:126
      sameAs:https://doi.org/10.1007/s10577-015-9505-5
      keywords:
         Aneuploidy
         Centrosome
         Chromosomal instability
         Cell Biology
         Human Genetics
         Animal Genetics and Genomics
         Plant Genetics and Genomics
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10577-015-9505-5/MediaObjects/10577_2015_9505_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10577-015-9505-5/MediaObjects/10577_2015_9505_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10577-015-9505-5/MediaObjects/10577_2015_9505_Fig3_HTML.gif
      isPartOf:
         name:Chromosome Research
         issn:
            1573-6849
            0967-3849
         volumeNumber:24
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Netherlands
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Marco Raffaele Cosenza
            affiliation:
                  name:University of Heidelberg
                  address:
                     name:Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Alwin Krämer
            affiliation:
                  name:University of Heidelberg
                  address:
                     name:Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Chromosome Research
      issn:
         1573-6849
         0967-3849
      volumeNumber:24
Organization:
      name:Springer Netherlands
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Heidelberg
      address:
         name:Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
         type:PostalAddress
      name:University of Heidelberg
      address:
         name:Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Marco Raffaele Cosenza
      affiliation:
            name:University of Heidelberg
            address:
               name:Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
               type:PostalAddress
            type:Organization
      name:Alwin Krämer
      affiliation:
            name:University of Heidelberg
            address:
               name:Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
      name:Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(706)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • AOS
  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.72s.